Clinical Trials › NCT06495593
Enrolling by InvitationPhase 4
Effects of Ocrelizumab Treatment on Immune Cells in Lymph Nodes in Multiple Sclerosis
Sponsored by University of California, San Francisco
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 5
Target enrollment
1
U.S. states
Feb 2025
Start date
Jun 2027
Expected completion
Interventions / Treatments
Ocrelizumab
Conditions studied
Multiple Sclerosis, Relapsing-Remitting
Where this trial is running (1 site)
California1 site
San Francisco
Participating MS centers on MS Buddy (1)
UCSF Multiple Sclerosis Center
San Francisco, CA
San Francisco, CA
MS centers in California
Compare treatment centers near a trial site by center type, providers and trials.
View California centersMore Phase 4 trials
Browse all Phase 4 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.